Why is PetMed Express stock gaining today?

PetMed Express stock traded higher in after-hours at $1.21, reaching an intraday peak of $1.27, as investors weighed a new strategic partnership announcement against a mixed earnings report released after the close of regular trading.

The company unveiled a white-label pharmacy agreement with Pet Supermarket, under which PetMeds will supply prescription medications, preventatives, and health products through Pet Supermarket’s retail stores and digital platforms, leveraging its licensed pharmacy infrastructure and ability to ship to all 50 states.

On the earnings front, the company reported a net loss of $0.31 per share for the quarter ended September 30, 2026, significantly wider than analyst consensus, while revenue of $35.8 million fell well short of estimates and declined roughly 19% from the prior-year period, weighed down by lower prescription medication sales and an unfavorable product mix shift. However, the net loss did narrow compared to the $8.5 million loss recorded in the same quarter a year ago, aided by reduced general and administrative expenses and lower advertising costs. CEO Jeff Willard noted that the company had stabilized operations and cut customer acquisition costs by 32% year-over-year, framing the quarter as a step toward building a leaner, more profitable business.

From a competitive and sector perspective, pet industry peer Pet Valu reported stronger-than-expected third-quarter results on the same day, with same-store sales returning to positive growth — a development that lent some optimism to the broader pet retail and services space. The wider market provided a modestly constructive backdrop, with the S&P 500 up 0.1%, the Dow Jones edging 0.1% higher, and the NASDAQ gaining 0.2% during the session.

Taken together, the combination of the Pet Supermarket partnership — which signals a continued push into white-label B2B pharmacy services — and signs of incremental operational improvement helped sustain investor interest in the stock, even as the headline earnings and revenue figures disappointed, leaving shares trading near the lower end of their intraday range in after-hours.